Abstract
Coxiella burnetii cardiovascular prosthetic infections are associated with high morbidity and mortality and represent a major health problem due to the lack of standardized management. We were confronted with a C. burnetii infection on Bentall-De Bono prosthesis characterized by a history of vascular infection with relapse that prompted us to screen for cases of C. burnetii on Bentall-De Bono vascular prosthesis monitored in our center. We screened patients between 1991 and 2019, from the French national reference center for Q fever. A microbiological criterion in addition to a lesional criterion was necessary to diagnose C. burnetii persistent vascular infection. Two thousand five hundred and eighty two patient were diagnosed with Coxiella burnetii infection and 160 patients with persistent C. burnetii vascular infection prosthesis, 95 of whom had a vascular prosthesis, including 12 with Bentall-De Bono prosthesis. Among patients with persistent C. burnetii prosthetic vascular infection, patients with Bentall-De Bono prostheses were significantly more prone to develop complications such as aneurysm, fistula, and abscess (62 versus 32%, two-sided Chi-square test, p = 0.04). All but one patient were treated with doxycycline and hydroxychloroquine for a mean (± standard deviation) period of 29.4 ± 13.6 months. Among the 12 patients, 5 had cardio-vascular complications, and 5 had prolonged antibiotherapy with doxycycline and hydroxychloroquine. Patients with C. burnetii vascular infection on Bentall-De Bono tend to be at high risk of developing complications (fistula, aneurysm, abscess, death). Surgery is rarely performed. Clinical, serological, and PET scanner imaging follow-up is recommended.
Similar content being viewed by others
Abbreviations
- PET:
-
Positron emission tomography
- PCR:
-
Polymerase chain reaction
- IHU :
-
Institut Méditerranée Infection
- TTE:
-
Transthoracic echocardiography
- TOE:
-
Transesophageal echocardiography
- D:
-
Doxycycline
- H:
-
Hydroxychloroquine
- NA:
-
Not available
- PCR:
-
Polymerase chain reaction
References
Kremer J, Mutters NT, Karck M, Last K (2018) Pulmonary valve prosthesis endocarditis caused by Coxiella burnetii. Thorac Cardiovasc Surg Rep 7(1):e47–e49. https://doi.org/10.1055/s-0038-1675841
Melenotte C (2018) Clinical features and complications of Coxiella burnetii infections from the French National Reference Center for Q fever. JAMA Network Open August 24:1–15
Million M, Thuny F, Richet H, Raoult D (2010) Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis 10(8):527–535. https://doi.org/10.1016/S1473-3099(10)70135-3
Maurin M, Raoult D (1999) Q Fever. Clin Microbiol Rev 12(4):518–553
Karhof S, van Roeden SE, Oosterheert JJ et al (April 2018) Primary and secondary arterial fistulas during chronic Q fever. J Vasc Surg. https://doi.org/10.1016/j.jvs.2018.01.044
Eldin C, Mailhe M, Lions C et al (2016) Treatment and prophylactic strategy for Coxiella burnetii infection of aneurysms and vascular grafts: a retrospective cohort study. Medicine (Baltimore) 95(12):e2810. https://doi.org/10.1097/MD.0000000000002810
Melenotte C, Million M, Hartung O et al (2012) Query rectal bleeding. Lancet Lond Engl 380(9839):446. https://doi.org/10.1016/S0140-6736(12)60470-X
Cahill TJ, Prendergast BD (2016) Infective endocarditis. Lancet Lond Engl 387(10021):882–893. https://doi.org/10.1016/S0140-6736(15)00067-7
Fournier PE, Marrie TJ, Raoult D (1998) Diagnosis of Q fever. J Clin Microbiol 36(7):1823–1834
Eldin C, Mélenotte C, Mediannikov O et al (2017) From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev 30(1):115–190. https://doi.org/10.1128/CMR.00045-16
Nashef SAM, Roques F, Sharples LD et al (2012) EuroSCORE II. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg 41(4):734–744; discussion 744-745. https://doi.org/10.1093/ejcts/ezs043
Edouard S, Million M, Casalta J-P, Collart F, Amphoux B, Raoult D (2017) Low antibodies titer and serological cross-reaction between Coxiella burnetii and legionella pneumophila challenge the diagnosis of mediastinitis, an emerging Q fever clinical entity. Infection. 45(6):911–915. https://doi.org/10.1007/s15010-017-1048-6
Botelho-Nevers E, Fournier P-E, Richet H et al (2007) Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 26(9):635–640. https://doi.org/10.1007/s10096-007-0357-6
Di Bartolomeo R, Berretta P, Petridis FD et al (2013) Reoperative surgery on the thoracic aorta. J Thorac Cardiovasc Surg 145(3 Suppl):S78–S84. https://doi.org/10.1016/j.jtcvs.2012.11.055
Hagl C, Strauch JT, Spielvogel D et al (2003) Is the Bentall procedure for ascending aorta or aortic valve replacement the best approach for long-term event-free survival? Ann Thorac Surg 76(3):698–703 discussion 703
Bentall Procedure: A Systematic Review and Meta-Analysis. - PubMed - NCBI. https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.athoracsur.2015.10.090. Accessed February 19, 2019
Bentall H, De Bono A (1968) A technique for complete replacement of the ascending aorta. Thorax. 23(4):338–339
Joo H-C, Chang B-C, Youn Y-N, Yoo K-J, Lee S (2012) Clinical experience with the Bentall procedure: 28 years. Yonsei Med J 53(5):915–923. https://doi.org/10.3349/ymj.2012.53.5.915
Broos PPHL, Hagenaars JCJP, Kampschreur LM et al (2015) Vascular complications and surgical interventions after world’s largest Q fever outbreak. J Vasc Surg 62(5):1273–1280. https://doi.org/10.1016/j.jvs.2015.06.217
Melenotte C, Million M, Raoult D (2019) New insights in Coxiella burnetii infection: diagnosis and therapeutic update. Expert Rev Anti-Infect Ther:1–12. https://doi.org/10.1080/14787210.2020.1699055
Chronic Q fever: expert opinion versus literature analysis and consensus - Journal of Infection. https://www.journalofinfection.com/article/S0163-4453(12)00106-5/fulltext. Accessed February 24, 2019
Rolain J-M, Boulos A, Mallet M-N, Raoult D (2005) Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis. Antimicrob Agents Chemother 49(7):2673–2676. https://doi.org/10.1128/AAC.49.7.2673-2676.2005
Melenotte C, Drancourt M, Gorvel JP, Mège JL, Raoult D (February 2019) Post-bacterial infection chronic fatigue syndrome is not a latent infection. Med Mal Infect. https://doi.org/10.1016/j.medmal.2019.01.006
Eldin C, Melenotte C, Million M et al (2016) 18F-FDG PET/CT as a central tool in the shift from chronic Q fever to Coxiella burnetii persistent focalized infection: a consecutive case series. Medicine (Baltimore) 95(34):e4287. https://doi.org/10.1097/MD.0000000000004287
Melenotte C, Million M, Audoly G et al (2016) B-cell non-Hodgkin lymphoma linked to Coxiella burnetii. Blood. 127(1):113–121. https://doi.org/10.1182/blood-2015-04-639617
Funding source
URMITE, IHU Méditerranée Infection. This work was supported by the French Government under the « Investissements d’avenir » (Investments for the Future) program managed by the Agence Nationale de la Recherche (ANR, fr: National Agency for Research), (reference: Méditerranée Infection 10-IAHU-03). This work was also supported by Région Provence-Alpes-Côte d’Azur and European funding FEDER PRIMMI (Fonds Européen de Développement Régional - Plateformes de Recherche et d’Innovation Mutualisées Méditerranée Infection).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ghellab, L., Melenotte, C., Million, M. et al. Persistent Coxiella burnetii cardiovascular infection on Bentall-De Bono prosthesis. Eur J Clin Microbiol Infect Dis 39, 1003–1010 (2020). https://doi.org/10.1007/s10096-020-03816-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-020-03816-9